Respirology Search
Respirology Respirology

Conference Reports

ESCMID Conference on Corona Virus Disease (ECCVID)

virtual
23 September 2020 - 25 September 2020

European Respiratory Society (ERS) International Congress 2020

Vienna
05 September 2020 - 09 September 2020

American Thoracic Society (ATS) 2020 Virtual

05 August 2020 - 10 August 2020

World Conference on Lung Cancer (WCLC) 2020 - Virtual Presidential Symposium

08 August 2020 - 08 August 2020

European Respiratory Society (ERS) International Congress 2019

Madrid
28 September 2019 - 02 October 2019

American Thoracic Society 2019 (ATS 2019) International Conference

Dallas, Texas, US
17 May 2019 - 22 May 2019

European Lung Cancer Congress 2019 (ELCC 2019)

Geneva, Switzerland
10 April 2019 - 13 April 2019

International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer (WCLC 2018)

Toronto
23 September 2018 - 26 September 2018

European Respiratory Society (ERS) International Congress 2018

15 September 2018 - 19 September 2018

American Thoracic Society International Conference 2018 (ATS 2018)

San Diego, California, US
18 May 2018 - 23 May 2018

European Lung Cancer Congress (ELCC) 2018

Geneva
11 April 2018 - 14 April 2018

American Academy of Allergy, Asthma, and Immunology/World Allergy Organization Joint Congress 2018 (AAAAI/WAO 2018)

Orlando, Florida, US
02 March 2018 - 05 March 2018

Congress of Asian Pacific Society of Respirology (APSR 2017)

Sydney
23 November 2017 - 26 November 2017

International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC)

Yokohama, Japan
15 October 2017 - 18 October 2017
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Mepolizumab: Targeting eosinophils in severe asthma with precision medicine
Pearl Toh, 16 Sep 2020
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.
Stopping long-term mepolizumab may lead to exacerbations, loss of asthma control
Roshini Claire Anthony, 07 Oct 2020

In patients with severe eosinophilic asthma, cessation of mepolizumab may lead to increased exacerbations and reductions in asthma control, according to results of the COMET* trial.